Baseline total metabolic tumor volume assessed by 18FDG-PET/CT predicts outcome in advanced melanoma patients treated with pembrolizumab

被引:0
|
作者
Awada, G. [1 ]
Ozdemir, I. [2 ]
Schwarze, J. K. [1 ]
Daeninck, E. [1 ]
Gondry, O. [2 ]
Jansen, Y. [3 ]
Seremet, T. [1 ]
Keyaerts, M. [2 ]
Everaert, H. [2 ]
Neyns, B. [1 ]
机构
[1] Univ Ziekenhuis Brussel, Med Oncol, Brussels, Belgium
[2] Univ Ziekenhuis Brussel, Nucl Med, Brussels, Belgium
[3] Univ Ziekenhuis Brussel, Surg Oncol, Brussels, Belgium
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
21P
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Early Reassessment of Total Metabolic Tumor Volume on FDG-PET/CT in Advanced Melanoma Patients Treated with Pembrolizumab Predicts Long-Term Outcome
    Vermeulen, Sim
    Awada, Gil
    Keyaerts, Marleen
    Neyns, Bart
    Everaert, Hendrik
    CURRENT ONCOLOGY, 2021, 28 (03) : 1630 - 1640
  • [2] Baseline total metabolic tumour volume on [18F]FDG PET/CT as promising biomarker in advanced NSCLC patients treated with first line pembrolizumab
    Dall'Olio, F. G.
    Calabro, D.
    Conci, N.
    Argalia, G.
    Marchese, P.
    Fabbri, F.
    Fragomeno, B.
    Fanti, S.
    Ambrosini, V.
    Ardizzoni, A.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S756 - S756
  • [3] Baseline metabolic tumor burden on FDG PET/CT scans predicts outcome in advanced NSCLC patients treated with immune checkpoint inhibitors
    Seban, Romain-David
    Mezquita, Laura
    Berenbaum, Arnaud
    Dercle, Laurent
    Botticella, Angela
    Le Pechoux, Cecile
    Caramella, Caroline
    Deutsch, Eric
    Grimaldi, Serena
    Adam, Julien
    Ammari, Samy
    Planchard, David
    Leboulleux, Sophie
    Besse, Benjamin
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (05) : 1147 - 1157
  • [4] Baseline metabolic tumor burden on FDG PET/CT scans predicts outcome in advanced NSCLC patients treated with immune checkpoint inhibitors
    Romain-David Seban
    Laura Mezquita
    Arnaud Berenbaum
    Laurent Dercle
    Angela Botticella
    Cécile Le Pechoux
    Caroline Caramella
    Eric Deutsch
    Serena Grimaldi
    Julien Adam
    Samy Ammari
    David Planchard
    Sophie Leboulleux
    Benjamin Besse
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 1147 - 1157
  • [5] Prognostic Value of Metabolic Tumor Volume on Pretreatment F-18 FDG PET/CT in Patients with Advanced Melanoma Treated with Ipilimumab
    Ito, Kimiteru
    Teng, Rebecca
    Schoder, Heiko
    Weber, Wolfgang
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [6] Metabolic tumor volume assessed by 18F-FDG-PET/CT as a predictor of outcome in patients with multiple myeloma
    Fonti, R.
    Larobina, M.
    De Luca, S.
    Fabbricini, R.
    Catalano, L.
    Rotoli, B.
    Pace, L.
    Del Vecchio, S.
    Salvatore, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S354 - S354
  • [7] Metabolic Tumor Volume Assessed by 18F-FDG PET/CT for the Prediction of Outcome in Patients with Multiple Myeloma
    Fonti, Rosa
    Larobina, Michele
    Del Vecchio, Silvana
    De Luca, Serena
    Fabbricini, Rossella
    Catalano, Lucio
    Pane, Fabrizio
    Salvatore, Marco
    Pace, Leonardo
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (12) : 1829 - 1835
  • [8] TOTAL METABOLIC TUMOR VOLUME CHANGE DURING NEOADJUVANT CHEMOTHERAPY IN 18F-FDG-PET/CT PREDICTS OUTCOME IN ADVANCED EPITHELIAL OVARIAN CANCER
    Vallius, T.
    Hynninen, J.
    Kemppainen, J.
    Alves, V.
    Oksa, S.
    Matomaki, J.
    Auranen, A.
    Grenman, S.
    Seppanen, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 728 - 728
  • [9] F-18 FDG PET/CT metabolic tumor volume predicts outcome in patients with disseminated epithelial ovarian cancer
    Gallicchio, R.
    Capacchione, D.
    Giacomobono, S.
    Nardelli, A.
    Bozza, G.
    Sirignano, C.
    Troiani, L.
    Improta, G.
    Tempone, A.
    Nappi, A.
    Storto, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S269 - S269
  • [10] 18F-FDG-PET/CT based total metabolic tumor volume change during neoadjuvant chemotherapy predicts outcome in advanced epithelial ovarian cancer
    Tuulia Vallius
    Johanna Hynninen
    Jukka Kemppainen
    Victor Alves
    Kari Auranen
    Jaakko Matomäki
    Sinikka Oksa
    Johanna Virtanen
    Seija Grénman
    Annika Auranen
    Marko Seppänen
    European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 1224 - 1232